Taro Pharmaceutical
TARO
#5055
Rank
C$2.23 B
Marketcap
C$59.36
Share price
0.00%
Change (1 day)
6.59%
Change (1 year)

Taro Pharmaceutical (TARO) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : C$0.53 Billion

According to Taro Pharmaceutical's latest financial reports the company's total liabilities are C$0.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Taro Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-03-31C$0.54 B-5.79%
2022-03-31C$0.58 B-34.99%
2021-03-31C$0.89 B174.27%
2020-03-31C$0.32 B8.91%
2019-03-31C$0.29 B4.17%
2018-03-31C$0.28 B-0.04%
2017-03-31C$0.28 B-11.82%
2016-03-31C$0.32 B-19.82%
2015-03-31C$0.40 B39.43%
2014-03-31C$0.29 B32.91%
2013-03-31C$0.21 B
2011-12-31C$0.22 B33.04%
2010-12-31C$0.17 B-41.71%
2009-12-31C$0.29 B-21.5%
2008-12-31C$0.37 B14.04%
2007-12-31C$0.32 B-24.55%
2006-12-31C$0.43 B-10.76%
2005-12-31C$0.48 B24.15%
2004-12-31C$0.39 B13.58%
2003-12-31C$0.34 B100.49%
2002-12-31C$0.17 B22.55%
2001-12-31C$0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$159.74 B 30,006.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$107.25 B 20,113.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$156.85 B 29,460.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$45.03 B 8,388.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$84.66 B 15,855.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$86.39 B 16,182.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland